Journal Watch

karenskjeiKaren L. Skjei, M.D.
Assistant Professor,
Department of Neurology Co-Director,
Epilepsy Surgery Program Director,
Epilepsy Monitoring Unit,
Norton Children's Hospital

Dr. Karen Skjei is an assistant professor of Neurology and Pediatrics at the University of Louisville. She completed her undergraduate studies at Duke University, and her medical education at the University of California at San Francisco School of Medicine. She completed a residency in Pediatrics and a fellowship in Child and Adolescent Neurology at the Mayo Clinic in Rochester, New York. She completed a fellowship in Neurophysiology and Epilepsy at the Children’s Hospital of Philadelphia. Dr Skjei is currently Editor of the ICNApedia Journal Watch

86 results - showing 1 - 10
1 2 3 4 5 6 7 8 9
Ordering
 
0.0
 
0.0 (0)
LH Leslie H. Hayes & Archana A. Patel Updated October 09, 2020 75 0
Pediatrics
 
0.0
 
0.0 (0)
UY Uluc Yis Updated July 01, 2020 101 0
Krysko KM, Graves JS, Rensel M, Weinstock-Guttman B, Rutatangwa A, Aaen G, Belman A, Benson L, Chitnis T, Gorman M, Goyal MS, Harris Y, Krupp L, Lotze T, Mar S, Moodley M, Ness J, Rodriguez M, Rose J, Schreiner T, Tillema JM, Waltz M, Casper TC, Waubant E. US Network of Pediatric MS Centers. Real-world effectiveness of initial disease-modifying therapies in pediatric MS. Ann Neurol 2020 Apr 8.  doi: 10.1002/ana.25737
 
0.0
 
0.0 (0)
KS Kavita Srivastava Updated July 01, 2020 135 0
Huntsman RJ, Strueby L, Bingham W. Are Ketamine Infusions a Viable Therapeutic Option for Refractory Neonatal Seizures?
 
0.0
 
0.0 (0)
KO Kate Oyieke and Mohamed Oshi Updated June 18, 2020 147 0
Kate Oyieke, Mohamed Oshi, Jo Wilmshurst Red Cross War Memorial Children’s Hospital, Cape Town, South Africa Respiratory diseases caused by viral agents are one of the most critical problems in public health, as every year they are responsible for high rates of morbidity and mortality, mainly of young children, the elderly and immunocompromised individuals [1-3]. Viral respiratory pathogens have come to the fore as a major cause for pandemics and therefore a better understanding of their disease spectrum is of great public health significance [4, 5]. The current challenges (in case definition, symptom profiling, estimation of...
 
0.0
 
0.0 (0)
BM Britta McLaren and Phindi Mteshana Updated May 08, 2020 393 0
Advances in treatment of Spinal Muscular Atrophy (SMA) has been topical for a number of years. As new treatment options continue to gain FDA approval, the “snowball effect” continues to bring new insights into SMA management. Changing phenotypes, need for earlier patient identification and carrier testing, additional treatment avenues and the shifting of more attention to the non-neuromuscular aspects of SMA and quality of life were in the past, overwhelmingly overshadowed by the devastating neuromuscular consequences of SMA. The 4 articles that we have selected address some of these issues. The articles in our review are...
 
0.0
 
0.0 (0)
VT Voloshyn Taras & Karen Skjei Updated May 03, 2020 210 0
Commentary Voloshyn Taras, MD PhD Assistant Professor Kozyavkin International Rehabilitation Clinic, Truskavets, Ukraine Karen Skjei, MD Associate Professor University of Texas-Austin, Dell Medical School, Austin, Texas Infantile spasms (IS) or as they are currently termed epileptic spasms (ES), are characterized by a brief contraction followed by flexor, extensor, or mixed movements. The incidence of IS ranges from 2 to 3.5 in 10,000 live births, with onset during the first year of ...
 
0.0
 
0.0 (0)
J Jyotindra Narayan Goswami Updated May 08, 2020 217 0
 
0.0
 
0.0 (0)
AS An-Sofie Schoonjans and Karen Skjei Updated March 04, 2020 316 0
Eur J Paediatr Neurol. 2019 Nov;23(6):827-831.
86 results - showing 1 - 10
1 2 3 4 5 6 7 8 9

pleasedonate